ArticleiScience2022
Development of OX40 agonists for canine cancer immunotherapy.
Damien Ruiz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleiScience2022
Damien Ruiz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.